Literature DB >> 14612146

Regulation of dopamine transporter function and plasma membrane expression by dopamine, amphetamine, and cocaine.

Kristopher M Kahlig1, Aurelio Galli.   

Abstract

Pharmacological alterations in dopamine transporter (DAT) function not only modulate dopamine reuptake, but they can induce rapid changes in the plasmalemmal expression of the transporter. By modifying transporter membrane expression, drugs may alter the maximum rate of neurotransmitter clearance, shifting cellular transport capacity and disrupting normal receptor stimulation. DAT-interacting drugs include the illicit and highly abused psychostimulants amphetamine and cocaine. Regulation of transporter activity and plasma membrane expression by these drugs has been implicated in the long-term processes of reward and addiction. This review summarizes the regulation of DAT by transporter substrates and blockers with particular emphasis on the modulation of DAT cell surface expression by acute exposure to amphetamine and cocaine.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14612146     DOI: 10.1016/j.ejphar.2003.08.065

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  70 in total

Review 1.  Drug-induced sleep: theoretical and practical considerations.

Authors:  Jeffrey M Ellenbogen; Edward F Pace-Schott
Journal:  Pflugers Arch       Date:  2011-09-28       Impact factor: 3.657

2.  Insights in how amphetamine ROCKs (Rho-associated containing kinase) membrane protein trafficking.

Authors:  Christine Saunders; Aurelio Galli
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-25       Impact factor: 11.205

Review 3.  Catecholaminergic based therapies for functional recovery after TBI.

Authors:  Nicole D Osier; C Edward Dixon
Journal:  Brain Res       Date:  2015-12-19       Impact factor: 3.252

4.  Dopamine D3 autoreceptor inhibition enhances cocaine potency at the dopamine transporter.

Authors:  Molly M McGinnis; Cody A Siciliano; Sara R Jones
Journal:  J Neurochem       Date:  2016-08-15       Impact factor: 5.372

5.  Dopaminergic control of anxiety in young and aged zebrafish.

Authors:  Victoria Kacprzak; Neil A Patel; Elizabeth Riley; Lili Yu; Jing-Ruey J Yeh; Irina V Zhdanova
Journal:  Pharmacol Biochem Behav       Date:  2017-04-10       Impact factor: 3.533

Review 6.  Evolution of stimulants to treat ADHD: transdermal methylphenidate.

Authors:  Kennerly S Patrick; Arthur B Straughn; Jeb S Perkins; Mario A González
Journal:  Hum Psychopharmacol       Date:  2009-01       Impact factor: 1.672

7.  Differential effects of amphetamine isomers on dopamine release in the rat striatum and nucleus accumbens core.

Authors:  Paul E A Glaser; Theresa C Thomas; B Matthew Joyce; F Xavier Castellanos; Greg A Gerhardt
Journal:  Psychopharmacology (Berl)       Date:  2004-09-30       Impact factor: 4.530

8.  Differential regulation of accumbal dopamine transmission in rats following cocaine, heroin and speedball self-administration.

Authors:  Lindsey P Pattison; Scot McIntosh; Evgeny A Budygin; Scott E Hemby
Journal:  J Neurochem       Date:  2012-05-23       Impact factor: 5.372

9.  Intracellular methamphetamine prevents the dopamine-induced enhancement of neuronal firing.

Authors:  Kaustuv Saha; Danielle Sambo; Ben D Richardson; Landon M Lin; Brittany Butler; Laura Villarroel; Habibeh Khoshbouei
Journal:  J Biol Chem       Date:  2014-06-24       Impact factor: 5.157

10.  Amphetamine and methamphetamine differentially affect dopamine transporters in vitro and in vivo.

Authors:  J Shawn Goodwin; Gaynor A Larson; Jarod Swant; Namita Sen; Jonathan A Javitch; Nancy R Zahniser; Louis J De Felice; Habibeh Khoshbouei
Journal:  J Biol Chem       Date:  2008-12-01       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.